Our CEO Jeff Jonker sat down with Endpoint News to discuss Belharra’s new podcast series “Birth of a Biotech.” In the article he discusses the reason behind starting the seven-episode podcast series and his hopes for creating something that will start a conversation on research, clinical developments, and patient treatments.
Read more:
hhttps://endpts.com/belharra-ceo-talks-the-ins-and-outs-of-building-a-biotech-in-a-new-podcast/